Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Nowak

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|October 13, 2025
Primary CD34<sup>+</sup> cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243Daniel Nowak, Marie Demmerle, Alessa Klär, et al.
Blood|December 8, 2009
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterationsDaniel Nowak, Seishi Ogawa, Markus Müschen, et al.
Blood|January 20, 2018
Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantationHeike Pfeifer, Katharina Raum, Sandra Markovic, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Blood Neoplasia|June 2, 2025
Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell levelJohann-Christoph Jann, Nanni Schmitt, Alexander Streuer, et al.
Genes, Chromosomes & Cancer|April 11, 2012
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, et al.
British Journal of Haematology|January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromesVladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
Experimental Hematology|December 24, 2021
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromesEva Altrock, Carla Sens-Albert, Johann-Christoph Jann, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
Leukemia|June 26, 2021
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromesNanni Schmitt, Johann-Christoph Jann, Eva Altrock, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|October 13, 2025
Primary CD34<sup>+</sup> cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243Daniel Nowak, Marie Demmerle, Alessa Klär, et al.
Blood|December 8, 2009
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterationsDaniel Nowak, Seishi Ogawa, Markus Müschen, et al.
Blood|January 20, 2018
Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantationHeike Pfeifer, Katharina Raum, Sandra Markovic, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Blood Neoplasia|June 2, 2025
Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell levelJohann-Christoph Jann, Nanni Schmitt, Alexander Streuer, et al.
Genes, Chromosomes & Cancer|April 11, 2012
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, et al.
British Journal of Haematology|January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromesVladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
Experimental Hematology|December 24, 2021
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromesEva Altrock, Carla Sens-Albert, Johann-Christoph Jann, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
Leukemia|June 26, 2021
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromesNanni Schmitt, Johann-Christoph Jann, Eva Altrock, et al.
Pageof 5